New long COVID index highlights five symptom subtypes

Researchers provide a detailed report of the updated 2024 long COVID research index.

Clearmind Medicine Announces Collaboration with CTS Ltd., a Leading Pharmaceutical and Consumer Products Company | Psychedelic Invest

Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health

August 14, 2023

Long COVID patients exhibit significant cognitive slowing, new study finds

Researchers find that patients with long COVID exhibit moderate-to-severe cognitive slowing compared to controls, highlighting a distinct cognitive signature of post-COVID-19 condition.

December 7, 2023

New proposals for scientific misconduct investigations worry some research universities

Research universities are voicing concerns over some proposed changes to the process for reviewing scientific misconduct allegations, citing worries that new government requirements would hobble

December 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.